| Trial Identifier: | D9320C00001 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT02991911 |
| Start Date: | January 2017 |
| Primary Completion Date: | September 2019 |
| Study Completion Date: | September 2019 |
| Condition: | Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| French Translation | |
| German Translation | |
| Italian Translation |
| Country | Location |
|---|---|
| Switzerland | Chur, Switzerland, 7000 |
| United Kingdom | London, United Kingdom, SM2 5PT |
| United States of America, CT | New Haven, CT, United States of America, 06519 |
| United States of America, FL | Sarasota, FL, United States of America, 34232 |
| United States of America, VA | Norfolk, VA, United States of America, 23502 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company